Hilary Kramer

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Hilary Kramer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hilary Kramer:

Company Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. Director Option to purchase Common Stock 31,250 04 Sep 2025 Direct

Insider Reports Filed by Hilary Kramer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GTBP GT Biopharma, Inc. 04 Sep 2025 1 $0 4 Director 08 Sep 2025, 17:45
GTBP GT Biopharma, Inc. 07 May 2025 0 $0 3 Director 03 Jun 2025, 16:15